Chronic airway obstruction after successful treatment of tuberculosis and its impact on quality of life

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 7, 2015, Pages 808-810

  De La Mora, I Laniado ^a,b   Martinez Oceguera D ^a,b   Laniado Laborin R ^a,b,c  

^a Hospital General Tijuana   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^c Jalisco   (Mexico)

Author keywords

CAT questionnaire; COPD; Quality of life; Spirometry

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COPD ASSESSMENT TEST; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG CAVITATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEXICO; PREVALENCE; PRIORITY JOURNAL; PULSE OXIMETRY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE ASSESSMENT; SMOKING; THORAX RADIOGRAPHY; TREATMENT DURATION; COMPLICATION; LUNG FUNCTION TEST; MIDDLE AGED; OUTPATIENT DEPARTMENT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUBERCULOSIS, PULMONARY;

ADULT; AMBULATORY CARE FACILITIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; TUBERCULOSIS, PULMONARY;

EID: 84930800057     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0983     Document Type: Article

References (11)

1. Martin C J, Hallett W Y. The diffuse obstructive pulmonary syndrome in a tuberculosis sanatorium. II. Incidence and symptoms. Ann Intern Med 1961; 54: 1156-1164.
2. Allwood BW, Myer L, Bateman E D. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration 2013; 86: 76-85.
3. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000; 55: 32-38.
4. Jones P W, Harding G, Berry P, Wiklund I, Chen W H, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
5. Global Initiative for Chronic Obstructive Lung Disease. The global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. Updated 2015. Chapter 2: Diagnosis and assessment. Bethesda, MD, USA: GOLD, 2015. http://www.goldcopd.org/uploads/users/files/GOLD-Report-2015-Feb18.pdf Accessed March 2015.
6. Torre-Bouscoulet L, Pérez-Padilla R; Grupo de Trabajo del Studio PLATINO enMéxico. Adjustment of several spirometric reference equations to a population-based sample in Mexico. Salud Publica Mex 2006; 48: 466-473.
7. Forey B A, Thornton A J, Lee PN. Systematic review with metaanalysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 2011; 11: 36.
8. Lee S W, Kim Y S, Kim D S, Oh Y M, Lee S D. The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci 2011; 26: 268-273.
9. Hwang Y I, Kim J H, Lee C Y, et al. The association between airflow obstruction and radiologic change by tuberculosis. J Thorac Dis 2014; 6: 471-476.
10. Lee C H, Lee M C, Lin H H, et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLOS ONE 2012; 7: e37978.
11. Brassard P, Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med 2011; 183: 675-678.